Image-based analyses as a means of modifying Radiation Therapy to customize treatment based on an individual patient's prognosis or early response to treatment is a research area crucial to the success of this program project. Project 3 investigates the hypothesis that, given the underlying heterogeneity of tumors and normal organs and their response to treatment, anatomic, metabolic and physiologic images (as acquired in the clinical projects of this program) are best utilized for individualizing therapy by robustly identifying subvolumes that are more predictive than individual voxels or the entire tumor/normal organ as a w/hole, and providing these subvolumes as a spatial guide for radiation dose redistributions such as focal boosting.
Aim 1 will improve reconstruction of physiological images.
Aim 2 is to investigate methods of Identifying subvolumes predictive of response.
Aim 3 will improve the accuracy of mapping subvolumes to patients to guide modification of radiation therapy dose distributions. Pattern recognition techniques will be developed for subvolume identification, and correlated with outcomes (e.g. sites of local failure). Complementary and redundant information from different imaging methods (e.g. 11C Methionine PET and DCE MRI in gliomas) for local response prediction will be studied, as well as the reproducibility of imaging signals and extracted subvolumes (from test-retest data). Methods to improve physiological imaging and analysis, including direct analysis of pharmacokinetics via pattern recognition, and sparsely sampled parallel MR! reconstructed using compressed sensing to resolve organ movement and improve the temporal resolution and/or volumetric coverage, will be investigated. To guide therapy individualization, subvolumes need to be mapped geometrically to the treated patient, with uncertainties due to the limits of image registration accuracy. Finite element models will be investigated as atlases to regularize the intensity-based deformable alignment methods used to place these subvolumes in the space of treatment planning CT scans acquired for the purposes of planning and/or modifying treatment.

Public Health Relevance

While MRI, PET, and SPECT scans can help predict how an individual patient may respond differently to treatment than others with the same disease, methods to identify poorly responding parts of tumors or normal organs from these images are not yet developed. This project investigates ways to find the regions of a tumor that need further treatment or parts of normal organs that should be spared.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
2P01CA059827-16A1
Application #
8609642
Study Section
Special Emphasis Panel (ZCA1-RPRB-C (O1))
Project Start
1997-02-01
Project End
2019-04-30
Budget Start
2014-05-15
Budget End
2015-04-30
Support Year
16
Fiscal Year
2014
Total Cost
$376,323
Indirect Cost
$132,430
Name
University of Michigan Ann Arbor
Department
Type
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Ohri, Nitin; Tomé, Wolfgang A; Méndez Romero, Alejandra et al. (2018) Local Control After Stereotactic Body Radiation Therapy for Liver Tumors. Int J Radiat Oncol Biol Phys :
Mendiratta-Lala, Mishal; Gu, Everett; Owen, Dawn et al. (2018) Imaging Findings Within the First 12 Months of Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy. Int J Radiat Oncol Biol Phys 102:1063-1069
Wang, Shulian; Campbell, Jeff; Stenmark, Matthew H et al. (2018) A model combining age, equivalent uniform dose and IL-8 may predict radiation esophagitis in patients with non-small cell lung cancer. Radiother Oncol 126:506-510
Sapir, Eli; Tao, Yebin; Schipper, Matthew J et al. (2018) Stereotactic Body Radiation Therapy as an Alternative to Transarterial Chemoembolization for Hepatocellular Carcinoma. Int J Radiat Oncol Biol Phys 100:122-130
Hawkins, Peter G; Boonstra, Philip S; Hobson, Stephen T et al. (2018) Prediction of Radiation Esophagitis in Non-Small Cell Lung Cancer Using Clinical Factors, Dosimetric Parameters, and Pretreatment Cytokine Levels. Transl Oncol 11:102-108
Sun, Yilun; Hawkins, Peter G; Bi, Nan et al. (2018) Serum MicroRNA Signature Predicts Response to High-Dose Radiation Therapy in Locally Advanced Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys 100:107-114
Kong, Feng-Ming Spring; Li, Ling; Wang, Weili et al. (2018) Greater reduction in mid-treatment FDG-PET volume may be associated with worse survival in non-small cell lung cancer. Radiother Oncol :
Shilkrut, Mark; Sapir, Eli; Hanasoge, Sheela et al. (2018) Phase I Trial of Dose-escalated Whole Liver Irradiation With Hepatic Arterial Fluorodeoxyuridine/Leucovorin and Streptozotocin Followed by Fluorodeoxyuridine/Leucovorin and Chemoembolization for Patients With Neuroendocrine Hepatic Metastases. Am J Clin Oncol 41:326-331
Jackson, William C; Tao, Yebin; Mendiratta-Lala, Mishal et al. (2018) Comparison of Stereotactic Body Radiation Therapy and Radiofrequency Ablation in the Treatment of Intrahepatic Metastases. Int J Radiat Oncol Biol Phys 100:950-958
Miften, Moyed; Vinogradskiy, Yevgeniy; Moiseenko, Vitali et al. (2018) Radiation Dose-Volume Effects for Liver SBRT. Int J Radiat Oncol Biol Phys :

Showing the most recent 10 out of 289 publications